Advancing Therapies for Patients

Find a clinical trial

page image

About Us

shadow image

Text Size

minus image

plus image

plus image

Print

Print image

Email a Friend

About Us

Find a clinical trial

Our Team

Dee Anna Smith

Dee Anna Smith

Chief Executive Officer, Sarah Cannon

Dee Anna Smith is the chief executive officer of Sarah Cannon, the global cancer enterprise of Hospital Corporation of America (HCA). Smith is responsible for carrying out the overall strategic mission and vision of Sarah Cannon, which delivers a full suite of physician-led, patient-centric integrated cancer services.  Sarah Cannon also maintains a focus on clinical research through the Sarah Cannon Research Institute (SCRI), one of the largest global strategic research organizations.

Smith joined SCRI in 2005 as chief information officer and also served as president of SCRI Services, leading the development of corporate strategy and vision for that division of SCRI. Prior to joining SCRI, Smith served as chief executive officer of Summit Research Solutions, a multi-specialty organization that she co-founded in 1996. SCRI acquired Summit Research Solutions in 2005. Smith graduated from Pepperdine University with a Bachelor of Arts in Accounting and began her career in 1986 in audit for KPMG, where she worked until 1992.

She is a member of the American Institute of Certified Public Accountants, American Society of Clinical Oncology and sits on the Board of Directors for the Nashville Health Care Council and PearlPoint Cancer Support. She is also a member of the Board of Visitors for the Lipscomb University School of Pharmacy and the Pepperdine Business Advisory Council.

hero1 image
Back to Team image

Latest Videos

watch the latest videos.

Learn more

News

news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals
LOC